Optimation of Avicel PH 102 with Cab-O-Sil M-5P Ratio and Crospovidone Concentration on Liquisolid System Piroxicam Tablet

T.N. Saifullah Sulaiman; Rani Puspita; Mutmainah Mutmainah

doi:10.22146/farmaseutik.v13i1.38466

Optimation of Avicel PH 102 with Cab-O-Sil M-5P Ratio and Crospovidone Concentration on Liquisolid System Piroxicam Tablet

https://doi.org/10.22146/farmaseutik.v13i1.38466

T.N. Saifullah Sulaiman^(1*), Rani Puspita⁽²⁾, Mutmainah Mutmainah⁽³⁾

(1) Fakultas Farmasi, Universitas Gadjah Mada Yogyakarta
(2) Sekolah Tinggi Ilmu Farmasi “Yayasan Pharmasi” Semarang
(3) Sekolah Tinggi Ilmu Farmasi “Yayasan Pharmasi” Semarang
(*) Corresponding Author

Abstract

Piroxicam is slightly soluble, so it should be developed in a liquisolid system of tablet dosage form to increase its solubility in gastrointestinal tract. Factorial design was applied to optimize the formula of liquisolid system piroxicam tablet by using four formulas: run I (18%A-2%B), run II (45%A-2%B), run III (18%A-5%B), and run IV (45%A-5%B). Component A is the ratio of Avicel PH 102 with Cab-O-Sil M-5P whether B is the concentration of crospovidone. Optimum formula was determined by superimposed contour plot from various parameters: hardness, friability, disintegrating time, and dissolution concentration (C₄₅) using Design Expert software. Based on superimposed contour plot, optimum formula area was obtained in the range of 18-45 of Avicel PH 102 with Cab-O-Sil M-5P ratio and 2-5% of crospovidone concentration.

Keywords

Piroxicam, Avicel PH 102, Cab-O-Sil M-5P, crospovidone, liquisolid

Full Text:

PDF

References

Balasubramaniam, J. dan Bee, T 2009., Influence of Superdisintegrant on The Rate of Dissolution from Oral Solid Dosage Forms, Pharmaceutical Technology, Supplement, April 2009, Advanstar Publication, USA Cabot Corp, 2015, CAB-O-SIL M-5P Technical Brochure, Cabot Corporation, Alpharetta Georgia, USA Departemen Kesehatan RI, 2014, Farmakope Indonesia Edisi V, Departemen Kesehatan RI., Jakarta FMC Biopolymer, 2005, Avicel® PH Technical Brochure, FMC Biopolymer, Philadelphia. Javadzadeh, Y., Navimipour, B., dan Nokhodchi, A. 2007. Liquisolid Technique for Dissolution rate Enhancement of a High Dose Water Insoluble Drug (Carbamazepine). Int. J. Pharm. 341: 26–34 Karataş, A., Yüksel N., Baykara T., 2005, Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol, II Farmaco, 60 (9): 777–782 Schwartz, J.B. dan Lachman L. 1990. Compressed Tablets by Direct Compression, in Bandeln J.F (Ed.). Pharmaceutical Dosage Form: Tablets Vol.1. New York, Basel, Hongkong: Marcel Dekker Inc Spireas, S. dan Sadu, S., 1998. Enhancement of Prednisolone Dissolution Properties Using Liquisolid Compacts. Int J Pharm. 166: 177- 188 Spireas, S. 2000. Liquisolid Systems and Methods of Preparing Same. U.S. Patent 6096337A Sulaiman, T. N. S. 2007. Teknologi dan Formulasi Sediaan Tablet. Yogyakarta : Fakultas Farmasi UGM.

DOI: https://doi.org/10.22146/farmaseutik.v13i1.38466